Please wait while the transcript is being prepared...
0:00
Hello. My name is
Henry Kaminski.
I'm a professor at George
Washington University,
and I've studied myasthenia gravis
for my entire medical career.
Today, I'll be talking to you about
understanding of myasthenia gravis
and recent advances
in its management.
0:19
A brief outline.
I'm going to discuss the
clinical presentation
and how myasthenia
gravis is diagnosed,
introduce the physiology
of myasthenia gravis,
and the standard of care
and emerging therapies,
which are very exciting
in our disease right now.
0:37
Let me first start with one of
the original descriptions of myasthenia
gravis by Sir Thomas Willis,
and allow me to read this.
"At this time I have under my
charge a prudent and honest woman,
who for many years
has been obnoxious to
this sort of spurious palsy.
Not only in her members,
but also in her tongue.
She for some time can speak
freely and readily enough,
but after she has spoke
long or hastily or eagerly,
she's not able to speak a word,
but becomes as mute as a fish.
Nor can she recover the use of
her voice under an hour or two."
This description has many key
features of myasthenia gravis.
The first one appreciates that
there are periods of normality.
She can speak
freely and readily,
but then she develops
fatigue to near muteness,
or entire muteness,
which I certainly have seen in
some patients during my career.
And then the weakness recovers.
A woman is described,
and so young women have a
propensity to develop this disease,
compared to men, in early years.
And Willis points out that
she's prudent and honest,
so there's a distinction
with psychiatric conditions.
Sadly, sometimes, myasthenia
gravis is confused with
and also delays the diagnosis
of actual myasthenia gravis.